Additionally, other anti-angiogenic proteins, such as tumstatin and arresten, were not investigated in this study, and it would be prudent for future studies to assess the associations between these proteins and MACEs in patients with PAD [57,58]. The gene discussed is COL4A1; the disease is peripheral arterial disease.